Azitra, Inc. (AZTR) Financial Ratios
5 years of historical data (2021–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.00
↓-100% vs avg
5yr avg: 0.82
30Y Low0.0·High2.2
ROE
↑
-0.6%
↓+100% vs avg
5yr avg: -198.7%
30Y Low-387%·High-1%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Azitra, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Market Cap | $2M | $1M | $2M | $6M | — | — |
| Enterprise Value | $-1643971712 | $-1644714509 | $-2392993 | $5M | — | — |
| P/E Ratio → | -0.08 | — | — | — | — | — |
| P/S Ratio | — | — | 0.21 | 9.24 | — | — |
| P/B Ratio | 0.00 | 0.00 | 0.28 | 2.18 | — | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | — | -0.32 | 7.91 | — | — |
| EV / EBITDA | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — |
Profitability
Margins and return-on-capital ratios measuring operating efficiency
Operating margins have compressed from -1086.1% to -146468.5% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -0.6% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Gross Margin | — | — | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | — | — | -146468.5% | -1086.1% | -3328.7% | -8383.1% |
| Net Profit Margin | — | — | -119.6% | -1644.9% | -3760.7% | -8127.0% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| ROE | -0.6% | -0.6% | -208.3% | -387.3% | — | — |
| ROA | -0.4% | -0.4% | -143.8% | -183.7% | -123.0% | -87.6% |
| ROIC | -0.8% | -0.8% | -445079.8% | -279.0% | — | — |
| ROCE | -0.6% | -0.6% | -231382.1% | -176.2% | -135.7% | -102.6% |
Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $2.1B exceeds total debt of $422M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Debt / Equity | 0.11 | 0.11 | 0.10 | 0.30 | — | — |
| Debt / EBITDA | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.43 | -0.70 | -0.31 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — |
| Interest Coverage | -1445.45 | -1445.45 | -903383.22 | -44.42 | -37.53 | -137.70 |
Net cash position: cash ($2.1B) exceeds total debt ($422M)
Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Azitra, Inc.'s current ratio of 2.83x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 1.58x to 2.83x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 2.83 | 2.83 | 3.80 | 1.58 | 1.86 | 7.02 |
| Quick Ratio | 2.83 | 2.83 | 3.80 | 1.58 | 1.86 | 7.02 |
| Cash Ratio | 1.94 | 1.94 | 3.31 | 1.12 | 1.57 | 6.65 |
| Asset Turnover | — | — | 1.02 | 0.13 | 0.04 | 0.01 |
| Inventory Turnover | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | 4.96 | 118.90 | 342.13 | 1108.86 |
Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Azitra, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $5M | $567568 | $34514 | $60493 | $60493 |
Peer Comparison
Compare AZTR with 7 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 AZTRYou | $2M | -0.1 | — | — | — | — | -0.6% | -0.8% | — |
 PHGE | $83B | -4.3 | — | — | — | — | -130.2% | -305.2% | — |
 ARMP | $420M | -22.2 | — | — | -565.4% | -820.2% | — | -44.2% | — |
 MCRB | $80M | -0.5 | — | — | — | — | 1.0% | -180.9% | — |
 EVGN | $7M | -0.3 | — | — | 39.8% | -255.4% | -75.8% | -102.4% | — |
 SYBX | $7M | -0.3 | — | — | 100.0% | -511875.0% | -84.3% | -205.7% | — |
 TOVX | $252100 | -0.0 | — | — | — | — | -87.3% | -142.7% | — |
 ELAB | $23875 | -0.0 | — | — | 72.8% | -75.7% | -119.1% | -82.7% | — |
| Healthcare Median | — | 23.2 | 14.9 | 19.0 | 65.8% | -6.4% | -36.7% | -13.6% | 3.0 |
Peers based on L4 peer group classification. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 5 years · Updated daily
See AZTR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AZTR Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare AZTR vs PHGE
See how AZTR stacks up against sector leader BiomX Inc..
Start ComparisonFrequently Asked Questions
What is Azitra, Inc.'s P/E ratio?
Azitra, Inc.'s current P/E ratio is -0.1x. This places it at the 50th percentile of its historical range.
What is Azitra, Inc.'s ROE?
Azitra, Inc.'s return on equity (ROE) is -0.6%. The historical average is -198.7%.
Is AZTR stock overvalued?
Based on historical data, Azitra, Inc. is trading at a P/E of -0.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.